Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Environmental Science and Pollution Research International|August 13, 2025
Unlocking nature's power: exploring phytoremediation for the biodegradation of low-density polyethylene through the application of the phytoconstituents of parboiled Curcuma longa L. rhizomeElsy Xavier, Nulgumnalli Manjunathaiah Raghavendra, Prashant Tiwari
Artificial Cells, Nanomedicine, and Biotechnology|March 9, 2022
Trans ethosomal hybrid composites of naproxen-sulfapyridine in hydrogel carrier: anti-inflammatory response in complete Freund's adjuvant induced arthritis ratsSajeev Kumar Babasahib, Roaddy Well Born, Nulgumnalli Manjunathaiah Raghavendra
European Journal of Medicinal Chemistry|January 24, 2020
Natural heat shock protein 90 inhibitors in cancer and inflammationThadeu E M M Costa, Nulgumnalli Manjunathaiah Raghavendra, Carmen Penido
Molecular Diversity|November 27, 2022
Molecular dynamics articulated multilevel virtual screening protocol to discover novel dual PPAR α/γ agonists for anti-diabetic and metabolic applicationsSubhankar Mandal, Syed Faizan, Nulgumnalli Manjunathaiah Raghavendra, et al.
Archives of Pharmacal Research|April 24, 2009
Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites CarcinomaNulgumnalli Manjunathaiah Raghavendra, Purvarga Mattada Gurubasavarajaswamy, Kanthappa Sathish Nagaranavile, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2012
Synthesis, pharmacological evaluation and docking studies of N-(benzo[d]thiazol-2-yl)-2-(piperazin-1-yl)acetamide analogs as COX-2 inhibitorsNulgumnalli Manjunathaiah Raghavendra, Aitha Jyothsna, Alapati Venkateswara Rao, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 6, 2012
Computer aided discovery of potential anti-inflammatory (S)-naproxen analogs as COX-2 inhibitorsNulgumnalli Manjunathaiah Raghavendra, Kota Ramakrishna, Vippula Sirisha, et al.
Bioorganic & Medicinal Chemistry|September 20, 2022
Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interactionPujan Sasmal, Sajeev Kumar Babasahib, B R Prashantha Kumar, et al.
European Journal of Medicinal Chemistry|November 12, 2017
Dual or multi-targeting inhibitors: The next generation anticancer agentsNulgumnalli Manjunathaiah Raghavendra, Divya Pingili, Sundeep Kadasi, et al.
Chemistry & Biodiversity|August 11, 2023
Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity RelationshipGhanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Pageof 3